Transcription Instability in High-risk Neuroblastoma is Associated with a Global Perturbation of Chromatin Domains
Overview
Authors
Affiliations
Chromosome instability has a pivotal role among the hallmarks of cancer, but its transcriptional counterpart is rarely considered a relevant factor in cell destabilization. To examine transcription instability (TIN), we first devised a metric we named TIN index and used it to evaluate TIN on a dataset containing more than 500 neuroblastoma samples. We found that metastatic tumors from high-risk (HR) patients are characterized by significantly different TIN index values compared to low/intermediate-risk patients. Our results indicate that the TIN index is a good predictor of neuroblastoma patient's outcome, and a related TIN index gene signature (TIN-signature) is also able to predict the neuroblastoma patient's outcome with high confidence. Interestingly, we find that TIN-signature genes have a strong positional association with superenhancers in neuroblastoma tumors. Finally, we show that TIN is linked to chromatin structural domains and interferes with their integrity in HR neuroblastoma patients. This novel approach to gene expression analysis broadens the perspective of genome instability investigations to include functional aspects.
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.
Murray J, Valli E, Milazzo G, Mayoh C, Gifford A, Fletcher J Nat Commun. 2024; 15(1):5585.
PMID: 38992040 PMC: 11239676. DOI: 10.1038/s41467-024-49871-0.
Why Is Aneuploidy Associated with Favorable Outcome in Neuroblastoma?.
Tonini G Biomolecules. 2021; 11(8).
PMID: 34439783 PMC: 8391846. DOI: 10.3390/biom11081116.
Garbati P, Barbieri R, Cangelosi D, Zanon C, Costa D, Eva A Biomedicines. 2020; 8(11).
PMID: 33153038 PMC: 7692293. DOI: 10.3390/biomedicines8110471.
Systematic computational identification of prognostic cytogenetic markers in neuroblastoma.
Qin C, He X, Zhao Y, Tong C, Zhu K, Sun Y BMC Med Genomics. 2019; 12(1):192.
PMID: 31831008 PMC: 6909636. DOI: 10.1186/s12920-019-0620-6.
Tonini G J Cancer. 2019; 10(12):2601-2603.
PMID: 31258767 PMC: 6584915. DOI: 10.7150/jca.33291.